Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-27T23:34:42.214Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychosocial factors in older heroin-dependent patients in treatment

Published online by Cambridge University Press:  04 August 2011

Harvinder Sidhu ,
Peter Crome  and
Ilana B Crome
Harvinder Sidhu
Affiliation:
Keele University Medical School, Keele, Staffordshire, UK
Peter Crome
Affiliation:
Keele University Medical School, Keele, Staffordshire, UK
Ilana B Crome*
Affiliation:
Keele University Medical School, Keele, Staffordshire, UK
*
Address for correspondence: Professor Ilana Crome, Academic Psychiatry Unit, Keele University Medical School, St George's Hospital, Corporation Street, Stafford ST16 3SR, UK. Email: pca03@keele.ac.uk
Get access Rights & Permissions [Opens in a new window]

Summary

The psychosocial characteristics of older heroin-dependent patients (defined as 45 years and over) attending a specialist addiction clinic in Stoke on Trent, UK were studied using retrospective record analysis of the case notes of the 20 oldest heroin-dependent patients. This study draws attention to the multiple psychosocial problems facing ageing heroin addicts. On average, patients were 48 years old, had first been exposed to heroin at age 29, 85% were injectors and the majority were polydrug users. In 20% a major life event had preceded first use of heroin. Nineteen were male, 17 were single, only 10% were employed, while just 10% did not have a criminal history. Depression, self-harm and memory disturbance were frequently reported. Retention in treatment was a feature, with consequent improvements including reduction in criminality and injecting behaviour. However, there is little specific guidance on treatment, training or policy for this group in the UK.

Keywords

heroin dependencyopiate dependencyolder people
Type
Psychological and social gerontology
Information
Reviews in Clinical Gerontology , Volume 22 , Issue 1 , February 2012 , pp. 79 - 83
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Barnas, C, Rossmann, M, Roessler, H, Reimer, Y, Fleischaker, WW. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: Familiarity and preference. J Clin Psychopharmacol 1992; 12: 397–402.CrossRefGoogle Scholar
2Bartram, L, Crome, P, McGrath, A, Corrado, O, Allen, SC, Crome, I. Geriatric medicine training in United Kingdom undergraduate medical schools. Age Ageing 2006; 35: 533–35.CrossRefGoogle ScholarPubMed
3Buttner, A, Rohrmoser, K, Mall, G, Penning, R, Weis, S. Widespread axonal damage in the brain of drug abusers as evidenced by accumulation of β-amyloid precursor protein (β-APP): An immunohistochemical investigation. Addiction 2006; 101: 1339–56.CrossRefGoogle ScholarPubMed
4Department of Health. National Service Framework for Older People. London: Department of Health, 2001.Google Scholar
5Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive. Drug Misuse and Dependence – UK guidelines on clinical management. London: Department of Health, 2007.Google Scholar
6Firoz, S, Carlson, G. Characteristics and treatment outcome of older methadone-maintenance patients. Am J Geriatr Psychiat 2004; 12: 539–41.CrossRefGoogle ScholarPubMed
7Frischer, M, Goldberg, D, Rahman, M, Berney, L. Mortality and survival among a cohort of drug injectors in Glasgow, 1982–1984. Addiction 1997; 92: 419–27.Google Scholar
8Gossop, M, Marsden, J, Stewart, D. The National Treatment Outcome Research Study (NTORS) after five years: Changes in substance use, health and criminal behaviour during the five years after intake. London: National Addiction Centre, 2001.Google Scholar
9Hoare, J. Drug Misuse Declared: Findings from the 2008/9 British Crime Survey England and Wales. London: Home Office, 2009.Google Scholar
10Hser, YI, Gelberg, L, Hoffman, V, Grella, CE, McCarthy, W, Anglin, MD. Health conditions among aging narcotic addicts: Medical examination results. J Behav Med 2004; 27: 607–22.CrossRefGoogle ScholarPubMed
11Hser, YI, Hoffman, V, Grella, C. A 33-year follow-up of narcotic addicts. Arch Gen Psychiat 2001; 58: 503–8.CrossRefGoogle Scholar
12The Information Centre. National Statistics: Statistics on drug misuse, England 2007. Available at: http://www.ic.nhs.uk/webfiles/publications/drugmisuse07/Drugs%20misuse-England%202007.pdf (accessed 30 April 2009).Google Scholar
13International Centre for Drug Policy. Substance misuse in the undergraduate medical curriculum. London: International Centre for Drug Policy, 2007.Google Scholar
14Moy, I, Crome, P, Frisher, M, Crome, I. Systematic review of treatment for older people with addiction problems. Eur Geriatr Med 2011 (in press).CrossRefGoogle Scholar
15National Collaborating Centre for Mental Health. Depression: Management of depression in primary and secondary care (National Clinical Practice Guideline 23), 2004. Available at: http://guidance.nice.org.uk/page.aspx?o=236667 (accessed 23 August 2007).Google Scholar
16National Institute for Health and Clinical Excellence (NICE). Methadone and buprenorphine for the management of opioid dependence (NICE Technology Appraisal Guidance 114). London: NICE, 2007.Google Scholar
17NICE. Naltrexone for the management of opioid dependence (NICE Technology Appraisal Guidance 115). London: NICE, 2007.Google Scholar
18NICE. Drug misuse: Psychosocial interventions (NICE Clinical Guideline 51). London: NICE, 2007.Google Scholar
19NICE. Drug misuse: Opioid detoxification (NICE Clinical Guideline 52). London: NICE, 2007.Google Scholar
20National Treatment Agency for Substance Misuse. Drug treatment in 2009–10. 2010; London: National Treatment Agency for Substance Misuse.Google Scholar
21Oppenheimer, E, Tobutt, C, Taylor, C, Andrew, T. Death and survival in a cohort of heroin addicts from London clinics: A 22 year follow up. Addiction 1994; 89: 1299–308.CrossRefGoogle Scholar
22Simoni-Wastila, L, Yang, H. Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother 2006; 4: 380–94.CrossRefGoogle ScholarPubMed
23US Department of Health & Human Services. Substance abuse among older adults (Treatment Improvement Protocol (TIP) Series 26). Rockville, MD: SAMSA, 1998.Google Scholar
24Bird, S, Hutchinson, S, Goldberg, D. Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000–01. Lancet 2003; 362: 941–44.CrossRefGoogle ScholarPubMed
25Bloor, R. Supervised methadone in Staffordshire and Shropshire: A study of factors associated with key outcome variable (Research briefing 25). London: National Treatment Agency 2007.Google Scholar